LysoPC directly changed the morphologic surface of melanoma cells and impaired cellular migratory ability on fibronectin and lung metastasis‐like lesions, by reducing integrin very late antigen‐4 ‐mediated binding to vascular cellular adhesion molecule‐1 and P‐selectin‐dependent interaction with activated platelets.14 Here, FN1 is linked to melanoma.